Synthesis of 1,3-olein-2-palmitin (OPO)

US11261401B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11261401-B2
Application numberUS-201816637401-A
CountryUS
Kind codeB2
Filing dateJul 26, 2018
Priority dateAug 11, 2017
Publication dateMar 1, 2022
Grant dateMar 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention concerns a highly selective process for the preparation of an ingredient comprising 1,3-Olein-2-palmitin (OPO), a triglyceride present in human breast milk. The present invention also relates to 1,3-Olein-2-palmitin (OPO) ingredient obtainable by the process.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for preparation of a 1,3-Olein-2-palmitin ingredient, the process comprising: subjecting 2-oxopropane-1,3-diyl dioleate to a reduction reaction under an anhydrous condition in a solvent system comprising tetrahydrofurane and in the presence of sodium borohydride to yield 2-hydroxypropane-1,3-diyl dioleate; partially removing and replacing the tetrahydrofurane with a solvent which is not miscible with water; adding acidulated water to inactivate the sodium borohydrate to form an inactivated mixture; separating an organic phase of the inactivated mixture; evaporating the solvent to recover the 2-hydroxypropane-1,3-diyl dioleate; and reacting the 2-hydroxypropane-1,3-diyl dioleate with palmitoyl chloride to yield the 1,3-Olein-2-palmitin. 2. The process according to claim 1 comprising: reacting 1,3-dihydroxyacetone with oleic acid or oleoyl chloride to yield the 2-oxopropane-1,3-diyl dioleate. 3. The process according to claim 1 comprising reacting 1,3-dihydroxyacetone in chloroform with oleoyl chloride in the presence of 2,6-lutidine at a temperature ranging from 0° C. to 25° C. to yield the 2-oxopropane-1,3-diyl dioleate. 4. The process according to claim 1 , wherein the solvent system consists of the tetrahydrofurane. 5. The process according to claim 1 , wherein the solvent system is selected from the group consisting of the tetrahydrofurane, the tetrahydrofurane/MeOH, the tetrahydrofurane/EtOH, and the tetrahydrofurane/MeOH/EtOH. 6. The process according to claim 1 , wherein the reduction reaction is performed at a temperature lower than 25° C. 7. The process according to claim 1 comprising reacting 1,3-dihydroxyacetone in chloroform with oleoyl chloride in the presence of pyridine or a pyridine derivative at a temperature ranging from 0° C. to 25° C. to yield the 2-oxopropane-1,3-diyl dioleate. 8. A 1,3-Olein-2-palmitin ingredient comprising a palmitic acid content at sn-2 position greater than 70% of a total palmitic content and by having a weight ratio of 1,3-Olein-2-palmitin to 3-(Palmitoyloxy)-1,2-propanediyl (9Z,9′Z)bis(-9-octadecenoate) or to 1-(Palmitoyloxy)-2,3-propanediyl (9Z,9′Z)bis(-9-octadecenoate) equal or higher than 90:10. 9. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the palmitic acid content at sn-2 position is equal or greater than 75% of the total palmitic content. 10. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the weight ratio of the 1,3-Olein-2-palmitin to the 3-(Palmitoyloxy)-1,2-propanediyl (9Z,9′Z)bis(-9-octadecenoate) or to the 1-(Palmitoyloxy)-2,3-propanediyl (9Z,9′Z)bis(-9-octadecenoate) is equal or greater than 92:8. 11. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the weight ratio of the 1,3-Olein-2-palmitin to the 3-(Palmitoyloxy)-1,2-propanediyl (9Z,9′Z)bis(-9-octadecenoate), or to the 1-(Palmitoyloxy)-2,3-propanediyl (9Z,9′Z)bis(-9-octadecenoate) is equal or greater than 95:5. 12. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the weight ratio of the 1,3-Olein-2-palmitin to the 3-(Palmitoyloxy)-1,2-propanediyl (9Z,9′Z)bis(-9-octadecenoate) or to the 1-(Palmitoyloxy)-2,3-propanediyl (9Z,9′Z)bis(-9-octadecenoate) is equal or greater than 98:2. 13. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the palmitic acid content at sn-2 position is equal or greater than 80% of the total palmitic content.

Assignees

Inventors

Classifications

  • by reduction of an oxygen containing functional group · CPC title

  • C11C3/003Primary

    by esterification of fatty acids with alcohols (C11C3/02 takes precedence) · CPC title

  • of >C=O containing groups, e.g. —COOH · CPC title

  • with fatty acids · CPC title

  • A23D9/02Primary

    characterised by the production or working-up · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11261401B2 cover?
The present invention concerns a highly selective process for the preparation of an ingredient comprising 1,3-Olein-2-palmitin (OPO), a triglyceride present in human breast milk. The present invention also relates to 1,3-Olein-2-palmitin (OPO) ingredient obtainable by the process.
Who is the assignee on this patent?
Nestle Sa
What technology area does this patent fall under?
Primary CPC classification C11C3/003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).